2017 Emerging Molecular Diagnostic Tests, and Strategic Profiles of Leading Reagent and Instrument Suppliers

January 2017 | 812 pages | ID: 2DF19B75BA0EN
Venture Planning Group

Abstracts

This 812-page report presents an overview of the clinical significance and market needs for major current and emerging tests, as well as extensive listings of companies developing and marketing molecular diagnostic technologies and products. This report also presents strategic assessments of current and emerging suppliers of molecular diagnostic products, including of their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Contains 812 pages and 35 tables

Contents

DNA and RNA Probe Technologies

1. BASIC PRINCIPLES
2. PROBE PREPARATION
3. THE DNA PROBE TEST
4. TEST FORMATS
5. LABELING TECHNIQUES
6. AMPLIFICATION METHODS

DETECTION TECHNOLOGIES

1. RADIOACTIVE METHODS
  a. Overview
  b. Major Isotopes
    P-32
    S-35
    H-3
    I-125
2. NON-ISOTOPIC METHODS
  a. Enzymatic Labels
  b. Chemical Labeling
    Indirect Chemical Labeling
    Direct Chemical Labeling
  c. Fluorescence
  d. Chemiluminescence
  e. Electrical Conductivity

Biochips: Genosensors, Microarrays, and Labs-on-the-Chip

Liquid Transportation and Mixing
Separation
Reaction
Detection

COMPETITIVE ASSESSMENTS

Abbott
Affymetrix
Agilent Technologies
Applied Gene Technologies
Arca Biopharma
Beckman Coulter/Danaher
Becton Dickinson
Biokit
bioMerieux
Bio-Rad
Biotest
Cepheid
CellMark Forensics/LabCorp
Decode Genetics
Diadexus
Eiken
Elitech Group
Enzo
Exact Sciences
Fujirebio
Grifols
Hologic/Gen-Probe
Illumina
Kreatech/Leica
Li-Cor Biosciences
Monogram Biosciences/LabCorp
Myriad Genetics
Ortho-Clinical Diagnostics
Perkin Elmer/Caliper
Proteome Sciences
Qiagen
Roche
Scienion
Sequenom
Shimadzu
Siemens
Sierra Molecular
Takara Bio
Tecan Group
Thermo Fisher